Literature DB >> 7518390

Mobile ionophores are a novel class of P-glycoprotein inhibitors. The effects of ionophores on 4'-O-tetrahydropyranyl-adriamycin incorporation in K562 drug-resistant cells.

M N Borrel1, E Pereira, M Fiallo, A Garnier-Suillerot.   

Abstract

The decrease of the intracellular concentration of drug in resistant cells compared to sensitive cells is, in most cases, correlated with the presence, in the membrane of resistant cells, of a 170-kDa P-glycoprotein responsible for an active efflux of the drug. In an attempt to identify mechanism(s) by which multidrug resistance can be circumvented, we have examined the cellular accumulation of 4'-O-tetrahydropyranyl-adriamycin, alone and in conjunction with various ionophores on the one hand and with cyclosporin A on the other hand. The present study was performed using a spectrofluorometric method with which it is possible to follow continuously the uptake and release of fluorescent molecules by living cells, as the incubation of the cells with the drug proceeds. Erythroleukemia K562 cell lines were used. Using experimental conditions in which these ionophores were unable to modify either the intracellular pH, or the transmembrane potential, or to induce an intracellular ATP depletion, we have shown that mobile ionophores as well as cyclosporin inhibit the P-glycoprotein-mediated efflux of 4'-O-tetrahydropyranyl-adriamycin in K562 resistant cells, whereas gramicidin, a channel-forming ionophore, does not. The concentration that must be used to inhibit 50% of the efflux was 0.7 microM for valinomycin, 0.4 microM for nonactin, 0.2 microM for nigericin, 1.1 microM for monensin, 0.4 microM for lasalocid, 1.2 microM for calcimycin and 0.4 microM for cyclosporin. Due to the high toxicity of the ionophores, the observation that they increased 4'-O-tetrahydropyranyl-adriamycin accumulation in the multidrug-resistant cells is not correlated with an effect of these compounds on drug resistance. However, the correlation exists in the case of cyclosporin. From our data showing that lipophilic neutral complexes, formed between carboxylic ionophores and metal ions, are both able to inhibit the P-glycoprotein-mediated efflux of anthracycline we can infer that the lipophilicity but not the cationic charge is an important physical property.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7518390     DOI: 10.1111/j.1432-1033.1994.tb18973.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  14 in total

1.  Decrease of P-glycoprotein activity in K562/ADR cells by MbetaCD and filipin and lack of effect induced by cholesterol oxidase indicate that this transporter is not located in rafts.

Authors:  Paiboon Reungpatthanaphong; Carole Marbeuf-Gueye; Laurence Le Moyec; Milena Salerno; Arlette Garnier-Suillerot
Journal:  J Bioenerg Biomembr       Date:  2004-12       Impact factor: 2.945

2.  Nonactin biosynthesis: the product of nonS catalyzes the formation of the furan ring of nonactic acid.

Authors:  A J Woo; W R Strohl; N D Priestley
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

Review 3.  Using purified P-glycoprotein to understand multidrug resistance.

Authors:  A B Shapiro; V Ling
Journal:  J Bioenerg Biomembr       Date:  1995-02       Impact factor: 2.945

4.  Genetic localization and molecular characterization of the nonS gene required for macrotetrolide biosynthesis in Streptomyces griseus DSM40695.

Authors:  W C Smith; L Xiang; B Shen
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

5.  Evidence against a role of P-glycoprotein in the clearance of the Alzheimer's disease Aβ1-42 peptides.

Authors:  Ivan Bello; Milena Salerno
Journal:  Cell Stress Chaperones       Date:  2015-01-16       Impact factor: 3.667

6.  Alternating pattern of stereochemistry in the nonactin macrocycle is required for antibacterial activity and efficient ion binding.

Authors:  Brian R Kusche; Adrienne E Smith; Michele A McGuirl; Nigel D Priestley
Journal:  J Am Chem Soc       Date:  2009-12-02       Impact factor: 15.419

Review 7.  Antitumor compounds from marine actinomycetes.

Authors:  Carlos Olano; Carmen Méndez; José A Salas
Journal:  Mar Drugs       Date:  2009-06-11       Impact factor: 5.118

8.  Nonactin biosynthesis: setting limits on what can be achieved with precursor-directed biosynthesis.

Authors:  Brian R Kusche; Joshua B Phillips; Nigel D Priestley
Journal:  Bioorg Med Chem Lett       Date:  2008-12-30       Impact factor: 2.823

9.  An overview of the evidence and mechanisms of herb-drug interactions.

Authors:  Pius S Fasinu; Patrick J Bouic; Bernd Rosenkranz
Journal:  Front Pharmacol       Date:  2012-04-30       Impact factor: 5.810

10.  Inhibitory Effects of Macrotetrolides from Streptomyces spp. On Zoosporogenesis and Motility of Peronosporomycete Zoospores Are Likely Linked with Enhanced ATPase Activity in Mitochondria.

Authors:  Md Tofazzal Islam; Hartmut Laatsch; Andreas von Tiedemann
Journal:  Front Microbiol       Date:  2016-11-18       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.